| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.9M | -17.6% |
| R&D Expense | $53.0M | -20.5% |
| SG&A Expense | $16.4M | -1.2% |
| Operating Income | -$43.5M | +16.1% |
| Pre-tax Income | -$33.3M | +27.2% |
| Income Tax | $0 | — |
| Net Income | -$33.3M | +27.2% |
| EPS (Basic) | -$0.45 | +36.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.6M | -67.2% |
| Short-term Investments | $20.5M | — |
| Accounts Receivable | $5.8M | +75.4% |
| Current Assets | $73.4M | -42.5% |
| Total Assets | $95.5M | -37.8% |
| Current Liabilities | $36.6M | -27.6% |
| Total Liabilities | $67.6M | -34.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.9M | -682.4% |
| Capital Expenditures | $1.0M | +9.7% |
| Investing Cash Flow | -$21.2M | -2137.7% |
| Financing Cash Flow | $7.2M | -87.8% |
| Free Cash Flow | -$61.0M | -608.2% |
| Stockholders' Equity |
| $27.9M |
| -45.0% |